bronchiti
inflammatori
condit
tracheobronchi
tree
commonli
present
acut
acut
exacerb
chronic
condit
bronchiti
peak
winter
month
respiratori
virus
preval
commun
recent
stratif
bronchiti
four
distinct
categori
suggest
first
categori
acut
tracheobronch
usual
viral
origin
requir
antibiot
therapi
second
simpl
chronic
bronchiti
forc
expiratori
volum
one
second
fev
greater
normal
increas
sputum
volum
purul
third
complic
chronic
bronchiti
increas
sputum
volum
purul
plu
least
one
follow
fev
greater
four
exacerb
per
year
advanc
age
comorbid
condit
like
congest
heart
failur
chf
categori
usual
caus
haemophilu
influenza
streptococcu
pneumonia
andor
moraxella
catarrhali
fourth
chronic
bronchial
infect
similar
categori
continu
sputum
product
throughout
year
often
associ
enter
gramneg
pathogen
includ
pseudomona
aeruginosa
acut
bronchiti
associ
gener
pulmonari
inflamm
infect
usual
caus
virus
rhinoviru
corona
viru
respiratori
syncyti
viru
rsv
influenza
viru
adenoviru
l
bordetella
pertussi
bordetella
parapertussi
mycoplasma
pneumonia
chlamydia
pneumonia
occasion
caus
acut
bronchiti
b
pertussi
consid
adult
cough
ill
last
acut
bronchiti
typic
begin
acut
viral
infect
manifest
cough
occasion
sputum
product
absenc
tachycardia
tachypnea
signific
fever
c
abnorm
chest
exam
product
sputum
predict
viral
bacteri
noninfecti
caus
cough
asthma
postnas
discharg
gastroesophag
reflux
caus
role
pneumonia
h
influenza
acut
bronchiti
demonstr
role
difficult
establish
organ
may
colon
normal
respiratori
acut
bronchiti
clinic
diagnosi
antimicrobi
therapi
uncompl
host
indic
bacteri
cultur
sputum
gram
smear
viral
studi
respiratori
secret
normal
help
may
major
except
adult
patient
suspect
pertussi
document
b
pertussi
attempt
cultur
serolog
sensit
specif
amplif
method
eg
polymeras
chain
reaction
pcr
avail
refer
laboratori
consensu
recommend
diagnosi
b
pertussi
pcr
propos
may
becom
gold
standard
diagnosi
pertussi
present
howev
singl
standard
pcr
method
avail
mani
laboratori
also
expertis
resourc
provid
cultur
detect
organ
direct
fluoresc
antibodi
dfa
stain
dfa
smear
suffer
interobserv
variabl
lack
sensit
specif
compar
cultur
calciumalgin
nasopharyng
swab
aspir
submit
appropri
transport
media
swab
never
transport
dri
choic
transport
medium
depend
time
requir
deliveri
specimen
laboratori
individu
laboratori
contact
appropri
transport
media
instruct
b
pertussi
becom
progress
difficult
cultur
cours
infect
adult
cours
may
protract
supplement
studi
may
increas
diagnost
yield
avail
combin
serolog
andor
pcr
conjunct
cultur
may
warrant
chronic
bronchiti
defin
continu
presenc
product
cough
least
period
consecut
year
character
cough
short
breath
secret
excess
mucu
caus
chronic
irrevers
inflammatori
chang
tracheobronchi
mani
environment
infecti
allerg
factor
contribut
chronic
bronchiti
ten
percent
adult
popul
may
affect
estim
million
peopl
unit
state
suffer
analysi
earli
morn
sputum
presenc
polymorphonuclear
granulocyt
pmn
eosinophil
ciliat
epitheli
cell
alveolar
macrophag
help
evalu
chronic
bronchiti
contrast
normal
patient
chronic
bronchiti
commonli
colon
lower
airway
potenti
pathogen
bacteria
pneurnonia
nonencapsul
h
infuenza
catarrhdi
role
bacteria
acut
exacerb
chronic
bronchiti
aecb
debat
evid
quantiti
lower
respiratori
tract
may
increas
increas
bacteri
number
may
stimul
overproduct
mucu
contribut
symptom
exacerb
probabl
result
number
factor
addit
bacteri
overgrowth
role
comorbid
condit
like
underli
heart
diseas
chronic
lung
diseas
immunosuppress
import
virus
includ
influenza
viru
parainfluenza
viru
rsv
rhinoviru
coronaviru
contribut
aecbl
pneurnonia
h
infuenza
found
least
half
patient
aecb
may
colon
patient
without
aecb
isol
rate
increas
symptomat
episod
b
pertussi
recogn
potenti
contributor
exacerb
anaerob
pneurnonia
commonli
found
aecb
c
pneurnonia
associ
mild
form
diseas
character
cough
last
week
bacteria
betahemolyt
streptococci
staphylococci
well
gramneg
enter
bacilli
rare
contribut
exacerb
found
sputum
cultur
patient
aecb
organ
commonli
present
respiratori
secret
patient
bronchiti
bacteri
cultur
sputum
littl
valu
isol
potenti
pathogen
confirm
role
aecb
smear
may
delin
presenc
predomin
organ
microbiolog
workup
respiratori
secret
rare
contribut
therapeut
decis
thu
requir
initi
therapi
direct
empir
normal
cover
pneumococci
haemophilu
moraxella
certain
clinic
set
patient
protract
cough
last
week
b
pertussi
conid
patient
need
microbiolog
evalu
usual
clinic
judgment
need
compromis
host
patient
multipl
myeloma
chronic
lymphocyt
leukemia
patient
longterm
corticosteroid
therapi
categori
recurr
aecb
pneumonia
rais
specter
underli
immunoglobulin
defici
acquir
hypogammaglobulinemia
pneumonia
sixth
common
infecti
diseaserel
caus
death
unit
statesl
least
four
million
case
pneumonia
year
discuss
concern
frequent
communityacquir
pneumonia
cap
rather
nosocomi
pneumonia
nap
clinic
manifest
cap
rare
specif
particular
microb
initi
manifest
may
includ
cough
product
sputum
fever
increas
respiratori
distress
preced
viral
syndrom
underli
chronic
lung
condit
may
worsen
sever
day
host
onset
abrupt
shake
chill
pleurit
chest
pain
obviou
toxic
extrem
age
often
atyp
present
elderli
present
increas
mental
confsion
physic
examin
help
distinguish
noninfecti
diseas
infect
exampl
chf
sign
underli
malign
sign
thromboembol
phenomena
hypertens
pulmonari
edema
howev
physic
examin
rare
provid
insight
specif
infect
caus
sign
consolid
chest
exam
includ
dull
percuss
increas
tactil
fremitu
increas
clariti
whisper
spoken
vocal
sound
bronchial
tubular
breath
sound
shorten
inspiratori
phase
prolong
expiratori
phase
inspiratori
crackl
usual
heard
presenc
heart
murmur
make
infect
endocard
consider
mental
statu
chang
rais
immedi
concern
mening
chest
radiographi
usual
defin
pneumonia
rare
pathognomon
specif
caus
pneumonia
diagnosi
specif
etiolog
pneumonia
requir
posit
cultur
blood
pleural
fluid
direct
lung
punctur
microorgan
invad
lower
respiratori
tract
primarili
way
aspir
oropharynx
inhal
aerosol
seed
lung
way
bloodstream
direct
extens
contigu
site
unusu
except
rightsid
endovascular
infect
pathogen
classic
caus
cap
chang
part
identif
pathogen
previous
recogn
legionella
speci
coxietla
burnetii
q
fever
c
pneumonia
preval
pathogen
influenc
underli
diseas
like
acquir
immunodefici
syndrom
aid
pneumoci
ti
cauinii
geograph
locat
coccidioidomycosi
southwestern
desert
q
fever
rural
nova
scotia
socioeconom
factor
tuberculosi
tb
howev
care
assess
patient
histori
epidemiolog
physic
examin
relev
preliminari
laboratori
inform
help
focu
differenti
diagnosi
toward
specif
etiolog
although
etiolog
commonli
deriv
colon
flora
oropharynx
bacteri
cultur
upper
respiratori
tract
secret
reliabl
identifi
etiolog
lower
respiratori
tract
infect
oropharynx
colon
plethora
aerob
anaerob
microorgan
flora
often
alter
chang
patient
immedi
environ
health
statu
colon
potenti
pathogen
organ
pneumonia
h
influenza
increas
season
protract
exposur
parent
children
attend
daycar
facil
gramneg
bacillari
colon
increas
rapidli
influenc
broadspectrum
antimicrobi
use
chronic
hospit
acut
sever
ill
chronic
ill
diabet
mellitu
alcohol
healthi
peopl
minim
sublaryng
bacteri
colon
chronic
ill
especi
pulmonari
acut
ill
associ
aspir
need
intub
caus
rapid
colon
lower
respiratori
tractm
microbi
caus
pneumonia
may
divid
two
group
commens
organ
normal
colon
upper
respiratori
tract
primarili
pneumonia
h
influenza
noncommens
organ
noncommens
organ
best
term
profession
pathogen
rare
colon
without
infect
pathogen
includ
mycobacterium
tuberculosi
mtb
legionella
speci
pneumocysti
carinii
fungi
specif
respiratori
virus
influenza
noncommens
organ
often
consid
certain
host
special
select
method
requir
identifi
isol
patient
clinic
pneumonia
often
establish
specif
caus
pneumonia
commens
organ
much
common
caus
pneumonia
requir
clinician
ask
organ
truli
caus
infect
mere
colon
respiratori
pneurnonia
common
caus
cap
especi
preval
patient
requir
hospitali
publish
incid
studi
cap
underestim
true
frequenc
pneumonia
diagnosi
specif
etiolog
rare
specif
etiolog
identif
often
requir
detect
normal
steril
site
blood
pleural
fluid
lung
gram
stain
wellcollect
sputum
show
mani
white
blood
cell
wbc
squamou
epitheli
cell
predomin
gramposit
lancetshap
diplococci
pneumonia
cultur
support
diagnosi
pneumococci
still
account
two
third
identifi
pathogen
hospit
patient
cap
patient
die
communityacquir
pneumonia
caus
pyogen
bacteria
h
influenza
aureu
enter
bacilli
preval
organ
rise
patient
age
legionella
pneumophila
legionella
speci
also
caus
cap
although
rare
seen
healthi
children
young
adult
preval
patient
age
year
frequenc
vari
geograph
may
neglig
certain
part
unit
like
legionella
pneumonia
c
pneumonia
atyp
etiolog
cap
predilect
younger
patient
underli
condit
chronic
obstruct
pulmonari
diseas
copd
diabet
mellitu
immunosuppress
addit
bacteri
etiolog
must
consid
legionella
speci
nocardia
speci
begin
play
promin
pathogen
role
rhodococcu
equi
gramposit
rod
aerob
actinomycet
group
caus
acut
chronic
pneumonia
patient
sever
immunocompromis
condit
especi
patient
aid
divid
two
categori
base
clinic
epidemiolog
characterist
caus
organ
member
tuberculosi
complex
includ
mtb
caus
tuberculosi
isol
mtb
clinic
specimen
consid
diagnost
mycobacteri
speci
includ
tb
complex
caus
nontubercul
mycobacteri
infect
collect
known
nontubercul
mycobacteria
ntm
ntm
infect
normal
present
chronic
pneumonia
patient
underli
respiratori
immunolog
problem
unlik
mtb
ntm
ubiquit
environ
transmit
persontoperson
may
found
water
dust
soil
even
domest
pet
except
mycobactevium
kansasii
clinic
signific
ntm
respiratori
secret
problemat
presenc
may
repres
transient
contaminat
certain
ntm
mycobacferium
avium
complex
mac
increas
frequenc
involv
younger
peopl
mani
without
appar
preexist
lung
women
infect
mac
often
men
may
indol
progress
clinic
present
cough
usual
without
weight
loss
fever
nodular
patchi
predomin
lower
lobe
infiltr
rare
cavit
may
progress
month
year
clinic
laboratori
need
identifi
ntm
isol
speci
level
therapeut
decis
requir
clinician
care
consid
issu
colon
versu
infect
look
patient
chest
radiograph
communityacquir
fungal
pneumonia
distinct
geograph
area
consid
patient
resid
travel
area
immunocompromis
host
increas
risk
certain
respiratori
fungi
coccidioidomycosi
afflict
patient
resid
travel
southwestern
sonoran
desert
state
part
latin
america
estim
new
case
c
immiti
infect
occur
annual
histoplasmosi
blastomycosi
must
consid
patient
visit
live
drainag
system
mississippi
ohio
river
histoplasma
capsulatum
consid
common
fungal
caus
respiratori
infect
estim
case
annual
case
histoplasmosi
coccidioidomycosi
selflimit
go
unrecogn
cryptococcu
neofovman
geograph
restrict
consid
immunocompromis
host
especi
central
nervou
system
involv
appar
isol
cryptococc
pneumonia
rare
pneumocysti
carinii
consid
fungu
also
includ
differenti
diagnosi
immunocompromis
host
especi
corticosteroid
aid
aspergilli
zygomycet
mold
rare
caus
cap
unless
neutropenia
diabet
ketoacidosi
profound
immunodefici
present
virus
especi
influenza
b
play
signific
role
cap
although
diagnos
children
age
frequent
signific
viral
caus
cap
includ
adenoviru
rsv
parainfluenza
virus
instanc
rhinovirus
recent
finnish
studi
hospit
pediatr
patient
cap
case
caus
virus
caus
season
outbreak
influenza
rsv
may
promot
adult
pneumonia
act
cofactor
worsen
bacteri
pneumonia
elderli
recent
influenza
infect
close
link
outbreak
sever
pneumococc
pneumonia
addit
hantaviru
caus
hantaviru
pulmonari
syndrom
hi
first
recogn
unit
state
new
mexico
hantavirus
zoonot
infect
wild
rodent
eg
deer
mice
transmit
human
aerosol
dri
excrement
although
first
hantaviru
found
four
comer
area
southwest
name
sin
nombr
viru
remain
import
hantaviru
case
document
throughout
unit
state
hp
rare
consid
healthi
adult
present
unexplain
pulmonari
edema
adult
respiratori
distress
synd
rm
e
evalu
patient
suspect
pneumonia
begin
comprehens
histori
physic
examin
chest
radiographi
confirm
presenc
pulmonari
inflamm
although
instanc
infiltr
may
scant
miss
dehydr
neutropenia
retrocardiac
locat
chest
radiographi
rare
pathognomon
specif
caus
pneumonia
routin
laboratori
studi
complet
blood
count
comprehens
chemistri
urinalysi
puls
oxymetri
help
establish
specif
etiolog
cap
assist
stratifi
patient
accord
sever
pneumonia
need
hospitali
use
diagnost
test
pneumonia
remain
question
guidelin
american
thorac
societi
at
infecti
diseas
societi
america
idsa
disagre
extent
diagnost
test
need
patient
capl
at
guidelin
recommend
empir
therapi
without
routin
microbiolog
workup
wherea
idsa
guidelin
support
workup
whenev
possibl
especi
patient
requir
hospit
microbiolog
diagnosi
cap
may
fail
patient
increas
success
microbiolog
diagnosi
usual
occur
patient
produc
sputum
treat
antibiot
requir
hospit
specif
microbi
diagnosi
allow
appropri
antimicrobi
select
detect
resist
organ
increas
worldwid
microbi
resist
may
forc
specif
diagnosi
cap
likewis
potenti
less
common
possibl
seriou
caus
cap
legionella
tb
nocardiosi
pneumocystosi
local
fungal
etiolog
need
consid
clinic
acumen
import
blood
andor
pleural
fluid
cultur
rare
posit
sputum
gram
stain
cultur
difficult
interpret
clinic
manifest
pneumonia
rare
specif
singl
pathogen
clinician
often
focu
like
etiolog
use
clinic
histori
wellcollect
examin
gram
stain
sputum
keep
mind
common
thing
happen
commonli
compromis
host
nursinghom
resid
patient
receiv
prior
antimicrobi
therapi
may
requir
broader
antimicrobi
coverag
acceler
invas
diagnost
workup
laboratori
diagnosi
specif
caus
cap
indic
ill
patient
especi
requir
hopit
specif
diagnosi
predic
avail
appropri
adequ
laboratori
resourc
inadequ
specimen
transport
time
commonli
result
misidentif
true
caus
pneumonia
specimen
collect
patient
receiv
antimicrobi
therapi
suscept
microorgan
rapidli
inhibit
therapi
begun
addit
sputum
evalu
specimen
may
collect
site
enhanc
diagnosi
tabl
two
routin
blood
cultur
collect
blood
cultur
rare
posit
therapi
initi
prior
collect
pleural
fluid
collect
thoracentesi
evalu
cultur
smear
blood
pleural
fluid
cultur
often
without
growth
howev
posit
cultur
diagnost
specif
caus
pneumonia
mycobacterium
tuberculosi
rapidgrow
acidfast
bacilli
avail
sensit
best
smearposit
specimen
pathogen
observ
smear
call
laboratori
avail
instruct
specif
although
amplif
method
use
polymeras
chain
reaction
avail
standard
difficult
interpret
time
recommend
routin
evalu
lower
respiratori
secret
diagnosi
communityacquir
pneumonia
ts
pneurnunia
haeniuphilu
bijuenza
moraxella
catawhali
enter
gramneg
rod
common
sdfa
direct
fluoresc
antigen
detect
specimen
coxiella
burnetti
q
fever
chlamydia
psittaci
psittacosi
francisella
tularensi
tularemia
yersinia
pesti
plagu
studi
detect
urinari
antigen
pneumococci
legionella
avail
clinic
use
either
still
question
pneumococcu
depend
geograph
preval
specif
serogroup
detect
sensit
pneumococc
antigen
urinari
test
although
surpass
gram
stain
may
vari
legionella
urinari
antigen
studi
includ
l
pneumophila
group
sensit
rang
clinic
use
may
depend
geograph
preval
serogroup
larger
studi
indic
substanti
benefit
urin
antigen
studi
initi
therapi
cap
yet
univers
product
sputum
care
acquir
analysi
patient
must
taught
appropri
collect
techniqu
secret
lower
respiratori
tract
expector
sputum
deep
cough
rather
collect
oropharyng
saliva
spit
essenti
induc
sputum
increas
recoveri
bacteria
mycobacteria
fungi
may
help
diagnosi
pneumocystosi
immunocompromis
induc
sputum
may
submit
mycobacteri
fungal
studi
expector
sputum
avail
swab
nasopharyng
secret
collect
sputum
use
appropri
storag
transport
must
avail
assur
specimen
integr
specimen
process
within
hour
refriger
viabil
pathogen
bacteria
potenti
overgrowth
commens
organ
alway
issu
specimen
process
rapidli
possibl
purul
area
sputum
screen
microscop
gram
stain
methylen
blue
wet
mount
low
magnif
adequaci
sever
criteria
compar
presenc
squamou
epitheli
cell
sec
polymorphonuclear
cell
pmn
predomin
morpholog
bacteria
evalu
presenc
increas
number
sec
x
magnif
field
pauciti
pmn
repres
specimen
inadequ
routin
bacteri
cultur
reject
fig
collect
addit
expector
sputum
specimen
routin
cultur
reject
initi
specimen
use
patient
begun
therapi
wellprepar
gram
stain
purul
sputum
demonstr
predomin
bacteri
morpholog
associ
wbc
use
guid
pathogenori
therapi
fig
sputum
gram
stain
demonstr
mani
wbc
organ
suggest
stealth
organ
viru
mycoplasma
c
pneumonia
legionella
speci
tubercdosi
absenc
mani
wbc
predomin
bacteri
morpholog
sputum
microscopi
use
gram
stain
view
road
map
sputum
cultur
grow
cultur
associ
wbc
smear
cultur
suspect
accept
sputum
specimen
inocul
onto
agar
media
allow
growth
common
bacteri
pathogen
help
provid
earli
differenti
speci
usual
batteri
media
clude
sheep
blood
agar
chocol
agar
mcconkey
agar
plate
media
incub
characterist
may
indic
result
gram
stain
slower
grow
bacteria
nocurdiu
requir
longer
incub
time
direct
commun
laboratori
essenti
whenev
deal
compromis
host
potenti
less
common
pathogen
requir
special
media
lengthi
incub
anaerob
cultur
recommend
expector
aspir
sputum
set
specimen
collect
biopsi
protect
bronchoscop
brush
organ
associ
wbc
note
direct
gram
stain
smear
specimen
evalu
fig
suscept
studi
indic
pathogen
note
gram
stain
isol
known
increas
resist
antimicrobi
agent
choic
vitro
antimicrobi
studi
laboratori
report
format
standard
recommend
nation
committe
clinic
laboratori
standard
nccl
presenc
fever
cough
pulmonari
infiltr
one
symptom
mental
confus
headach
abdomin
pain
elev
liver
enzym
bradycardia
heighten
suspicion
legionella
cultur
specif
request
special
pro
cess
select
nonselect
agar
media
buffer
charcoal
yeast
extract
supplement
aketoglutar
capabl
grow
legionella
necessari
cultur
respiratori
secret
remain
gold
standard
identifi
legionella
speci
method
avail
detect
legionella
l
pneumophila
secret
howev
alway
purul
may
clear
wateri
henc
cultur
set
without
screen
adequacym
ill
immunocompromis
patient
may
requir
bronchoalveolar
lavag
bal
lung
biopsi
andor
pleural
fluid
collect
specimen
legionella
cultur
may
refriger
hour
transport
frozen
longer
delay
antiip
pretreat
acid
recommend
sputum
patient
cystic
fibrosi
decreas
contamin
cultur
requir
incub
ambient
air
week
consid
neg
dfa
techniqu
detect
legionella
respiratori
secret
lack
adequ
sensit
specif
perform
sputum
enzym
immunoassay
eia
avail
detect
l
pneumophila
serogroup
antigen
urinem
test
may
use
area
high
preval
serogroup
organ
would
miss
serovari
legionella
recent
kit
detect
broad
group
legionella
becam
avail
perform
characterist
yet
serolog
studi
diagnosi
legionellosi
perform
antibodi
organ
develop
slowli
week
mani
peopl
live
endem
area
may
elev
titer
intracellular
natur
legionella
result
vitro
suscept
studi
frequent
correl
clinic
respons
normal
indic
avail
cultur
serolog
method
diagnosi
mycoplasma
infect
insensit
slow
use
recommend
routin
cap
respiratori
tract
infect
cold
agglutinin
studi
neither
sensit
specif
enough
warrant
use
diagnost
tool
test
immunoglobulin
igm
antibodi
ifa
enzymelink
immunosorb
assay
elisa
may
use
diagnosi
mycoplasma
pediatr
patient
specimen
collect
within
day
onset
symptom
howev
igm
antibodi
may
lack
introduct
rapid
method
laboratori
isol
identif
suscept
test
mycobacteria
significantli
improv
abil
diagnos
infect
caus
agent
averag
time
recoveri
acidfast
organ
cultur
decreas
day
cultur
identif
mtb
avium
complex
mac
possibl
within
day
specimen
setup
suscept
studi
mtb
primari
antituberculosi
agent
isoniazid
rifampin
streptomycin
ethambutol
perform
initi
isol
requir
addit
five
day
use
newer
technolog
radiometr
broth
techniqu
isol
suscept
test
molecular
probe
identif
mtb
mac
kansasii
cultur
enabl
introduct
highpressur
liquid
chromatograph
hplc
method
identifi
mycobacteria
evalu
characterist
presenc
longcarbon
chain
fatti
acid
mycol
acid
mycol
cell
wall
allow
rapid
accur
identif
ntm
well
mtb
notwithstand
newer
method
three
sputum
sampl
collect
three
separ
day
still
necessari
adequ
sampl
respiratori
secret
sputum
still
requir
decontamin
concentr
prior
inocul
special
auraminerhodamin
fluoresc
stain
remain
microscop
specimen
screen
method
choic
hard
diagnos
case
may
help
perform
bronchoscopi
follow
immedi
sever
expector
sputum
specimen
latter
increas
e
l
recent
molecular
amplif
method
becom
avail
diagnosi
mtb
sputum
specimen
method
high
sensit
specif
smear
show
afb
sensit
specif
poorer
predict
valu
afb
seen
smear
clinic
use
depend
clinician
suspect
tb
case
specif
isol
need
suscept
test
introduct
fluoresc
column
evalu
mycol
hplc
heighten
method
sensit
allow
potenti
use
respiratori
specimen
sensit
greatest
test
smearposit
specimen
hplc
analysi
ad
valu
ascertain
specif
speci
organ
present
specimen
rather
screen
mtb
routin
antimicrobi
suscept
test
mtb
mandatori
test
ntm
discourag
often
provid
erron
inform
therapi
routin
suscept
test
ntm
recommend
rapidli
grow
mycobacteria
fortuitum
chelonei
us
cs
u
diagnosi
fungal
infect
usual
includ
histolog
cultur
although
serolog
studi
critic
coccidioidomycosi
suspect
tabl
cultur
fungal
media
character
isol
phenotyp
morpholog
biochem
reaction
still
necessari
diagnos
mani
cs
e
stain
molecular
probe
increas
capabl
detect
organ
fluoresc
stain
directli
clinic
specimen
allow
rapid
identif
genet
probe
isol
cultur
introduc
calcofluor
white
stain
use
direct
visual
fungi
specimen
stain
incorpor
fluoresc
dye
bind
chitin
fungal
cell
wall
therebi
increas
sensit
direct
detect
unfortun
stain
organ
specif
experienc
personnel
requir
read
smear
accur
artifact
may
occur
sensit
fluoresc
monoclon
antibodi
specif
direct
visual
p
carinii
commerci
avail
becom
diagnost
method
choic
p
carinii
grow
cultur
media
bastomyc
dermafitidi
demonstr
readili
direct
microscop
examin
cultur
respiratori
specimen
bal
specimen
diagnost
case
dissemin
diseas
fungu
may
recov
bronchoscopi
specimen
skin
lesion
cerebrospin
fluid
csf
blood
diagnosi
coccidioidomycosi
establish
histolog
cultur
andor
serolog
microscop
evalu
sputum
specimen
rare
demonstr
spherul
sensit
microscopi
increas
specimen
bal
pleural
fluid
lung
biopsi
myceli
form
rather
spherul
may
present
specimen
collect
cavitari
lesion
coccidioid
immiti
easi
cultur
almost
alway
recover
within
week
presenc
spherul
direct
microscopi
diagnost
c
immiti
spherul
seen
clinic
materi
isol
ident
confirm
c
immiti
best
identifi
use
speciesspecif
genet
probe
genprob
san
diego
coccidioidomycosi
easili
diagnos
serolog
mean
skin
test
longer
avail
eia
detect
fungusspecif
antibodi
correl
igm
igg
class
avail
detect
igm
class
antibodi
requir
confirm
immunodiffus
id
tube
precipitin
tp
method
complement
fixat
cf
test
quantit
determin
igg
antibodi
use
diagnosi
prognosi
cf
titer
suggest
dissemin
howev
standard
procedur
cf
test
valu
obtain
differ
laboratori
may
differ
diagnosi
histoplasmosi
predic
progress
diseas
nondissemin
selflimit
infect
pulmonari
specimen
rare
reveal
thoracotomi
lung
biopsi
may
necessari
ill
patient
adequ
document
histoplasma
direct
microscop
visual
yeast
cell
poor
sensit
pulmonari
diseas
loo
dissemin
infect
dissemin
howev
recoveri
organ
possibl
blood
bone
marrow
skin
lesion
respiratori
secret
case
bone
marrow
provid
highest
yield
histoplasma
requir
day
week
recoveri
cultur
speciesspecif
genet
probe
avail
rapid
confirm
isol
ident
ident
may
also
confirm
convers
myceli
phase
growth
yeast
phase
eia
avail
rapid
diagnosi
histoplasmosi
detect
histoplasmaspecif
glycoprotein
antigen
bal
fluid
serum
urin
csf
test
sensit
greatest
dissemin
diseas
higher
urin
serum
less
acut
diseas
sensit
eia
drop
although
specif
eia
normal
high
falseposit
serum
result
occur
avoid
erron
interpret
serum
urin
specimen
submit
concurr
evalu
antigenemia
without
antigenuria
rare
find
rais
suspicion
falseposit
antigen
eia
studi
avail
histoplasmosi
refer
laboratori
indiana
univers
w
tenth
st
indianapoli
although
antibodi
produc
slowli
serolog
may
usefl
combin
immunodiffus
cf
test
sensit
approach
loo
except
immunocompromis
patient
may
mount
inadequ
respons
skin
test
histoplasmin
diagnost
valu
produc
antibodi
interfer
serolog
diagnosi
cryptococcu
neoforman
normal
contract
respiratori
tract
uncommonli
found
lung
dissemin
involv
skin
bone
marrow
central
nervou
system
find
cryptococci
lung
spur
care
evalu
infect
site
especi
central
nervou
system
cn
cryptococcu
neoformm
easili
isol
varieti
media
includ
routin
sheep
blood
agar
plate
fungal
media
grow
select
fungal
media
contain
cycloheximid
cryptococcu
grow
routin
bacteri
blood
cultur
often
requir
stain
subcultur
recognit
presenc
blood
cultur
medium
inadequ
stain
gram
stain
requir
fungal
stain
india
ink
prepar
visual
commerci
latex
agglutin
enzymelink
immunoassay
system
also
avail
rapid
detect
cryptococc
polysaccharid
antigen
csf
serum
infect
test
high
sensit
specif
dissemin
cryptococcosi
serum
antigen
detect
howev
use
infect
limit
respiratori
tract
sensit
drop
less
oyo
pneumocysti
carinii
caus
pneumonia
immunosuppress
tient
monoclon
fluoresc
antibodi
stain
directli
sputum
becom
diagnost
gold
standard
depend
experi
cytospin
centrifug
smear
prepar
induc
sputum
yield
carinii
wherea
transbronchi
biopsi
andor
bal
yield
oyo
expector
sputum
provid
poor
yield
aspergillosi
zygomycosi
often
incorrectli
refer
mucormycosi
seen
almost
exclus
compromis
host
includ
diabet
ketoacidosi
candida
speci
almost
never
caus
frank
cap
even
immunocompromis
patient
suscept
test
fungi
cover
separ
articl
seri
viral
pneumonia
may
diagnos
tissu
cell
line
cultur
viral
antigen
detect
method
directli
respiratori
secret
improv
tissu
cultur
techniqu
shell
vial
cultur
earli
detect
viral
replic
fluoresc
eia
molecular
techniqu
decreas
time
respiratori
viru
recoveri
hour
clinic
perspect
direct
fluoresc
antibodi
eia
method
detect
presenc
viru
directli
cytocentrifug
specimen
use
direct
test
method
particularli
use
virus
like
rsv
lose
viabil
transport
specimen
like
yield
posit
viral
result
includ
nasopharyng
np
aspir
follow
np
swab
throat
swab
submit
appropri
viral
transport
media
recent
introduct
antiinfluenza
b
therapi
led
prolifer
commerci
product
capabl
rapidli
detect
virus
clinic
unfortun
use
hinder
lack
sensit
clinic
benefit
studi
np
aspir
improv
sensit
compar
swab
nasopharynx
throat
influenza
therapi
timedepend
use
administ
within
first
hour
ill
major
patient
influenza
present
physician
within
hour
therapeut
intervent
base
rapid
test
would
late
therapi
articl
focus
evalu
outpati
lower
respiratori
ill
larg
part
need
microbiolog
workup
hostdepend
healthi
patient
usual
well
laboratori
data
often
unnecessari
abnorm
host
requir
differ
approach
gener
compromis
host
aggress
laboratori
evalu
renal
transplant
patient
respiratori
symptom
often
follow
dictum
common
thing
happen
commonli
howev
clinician
need
extra
level
assur
case
transplant
patient
may
respiratori
ill
caus
strongyloidiasi
cystic
fibrosi
anoth
exampl
need
comprehens
laboratori
evalu
special
select
media
addit
suscept
studi
may
need
evalu
isol
associ
exacerb
symptom
patient
clinic
laboratori
forewarn
materi
come
invas
diagnost
techniqu
prepar
offer
use
advic
regard
specimen
transport
followup
microbiolog
laboratori
often
knowledg
regard
type
test
appropri
direct
commun
laboratori
essenti
assur
best
patient
care
